• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

编码白细胞介素-6和血凝素的DNA共同给药可使小鼠免受流感病毒攻击。

Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice.

作者信息

Larsen D L, Dybdahl-Sissoko N, McGregor M W, Drape R, Neumann V, Swain W F, Lunn D P, Olsen C W

机构信息

Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison, 53706, USA.

出版信息

J Virol. 1998 Feb;72(2):1704-8. doi: 10.1128/JVI.72.2.1704-1708.1998.

DOI:10.1128/JVI.72.2.1704-1708.1998
PMID:9445082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC124660/
Abstract

This study was conducted to investigate whether Accell gene gun coadministration of DNA encoding human interleukin-6 (IL-6) would enhance protective immune responses in mice to an equine influenza A virus hemagglutinin (HA) DNA vaccine. Mice that received HA DNA alone exhibited accelerated clearance of homologous challenge virus but were not protected from infection. In contrast, mice that received both HA and IL-6 DNA had no detectable virus in their lungs after challenge. These results strongly support the use of IL-6 as a cytokine adjuvant in DNA vaccination.

摘要

本研究旨在调查通过Accell基因枪共同给予编码人白细胞介素-6(IL-6)的DNA是否会增强小鼠对马甲型流感病毒血凝素(HA)DNA疫苗的保护性免疫反应。单独接受HA DNA的小鼠对同源攻击病毒的清除加速,但未免受感染。相比之下,同时接受HA和IL-6 DNA的小鼠在攻击后肺部未检测到病毒。这些结果有力地支持了将IL-6用作DNA疫苗接种中的细胞因子佐剂。

相似文献

1
Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice.编码白细胞介素-6和血凝素的DNA共同给药可使小鼠免受流感病毒攻击。
J Virol. 1998 Feb;72(2):1704-8. doi: 10.1128/JVI.72.2.1704-1708.1998.
2
Effects of DNA dose, route of vaccination, and coadministration of porcine interleukin-6 DNA on results of DNA vaccination against influenza virus infection in pigs.DNA剂量、接种途径以及猪白细胞介素-6 DNA共同给药对猪流感病毒感染DNA疫苗接种结果的影响。
Am J Vet Res. 2002 May;63(5):653-9. doi: 10.2460/ajvr.2002.63.653.
3
Immunization with baculovirus displayed H6 hemagglutinin vaccine protects mice against lethal H6 influenza virus challenge.用杆状病毒展示的H6血凝素疫苗免疫可保护小鼠免受致死性H6流感病毒攻击。
Antiviral Res. 2014 Sep;109:42-53. doi: 10.1016/j.antiviral.2014.06.002. Epub 2014 Jun 25.
4
Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza.表达病毒蛋白的质粒DNA预防流感能力的比较
Vaccine. 1998 Oct;16(16):1544-9. doi: 10.1016/s0264-410x(98)00043-7.
5
Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice.在小鼠中通过共同给予编码病毒抗原和细胞因子的质粒DNA增强对病毒感染的保护作用。
J Clin Virol. 1999 Jun;13(1-2):17-27. doi: 10.1016/s1386-6532(99)00008-6.
6
Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.通过用表达血凝素和神经氨酸酶的DNA进行免疫接种,增强对致命流感病毒攻击的保护作用。
Vaccine. 1999 Feb 26;17(7-8):653-9. doi: 10.1016/s0264-410x(98)00247-3.
7
Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin.DNA疫苗针对血凝素对致死性H5N2流感病毒的交叉保护作用。
J Virol. 1997 May;71(5):3391-6. doi: 10.1128/JVI.71.5.3391-3396.1997.
8
Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.用DNA疫苗诱导针对甲型禽流感病毒亚型的保护的策略。
Vaccine. 2000 May 22;18(23):2592-9. doi: 10.1016/s0264-410x(99)00485-5.
9
Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.
Vaccine. 1997 Jul;15(10):1149-56. doi: 10.1016/s0264-410x(96)00309-x.
10
Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.编码血凝素基因的DNA疫苗对甲型流感病毒的保护机制。
Intervirology. 2000;43(4-6):322-30. doi: 10.1159/000054000.

引用本文的文献

1
Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines.细胞溶解性穿孔素作为增强DNA疫苗免疫原性的佐剂。
Vaccines (Basel). 2019 Apr 30;7(2):38. doi: 10.3390/vaccines7020038.
2
A Review of DNA Vaccines Against Influenza.抗流感DNA疫苗综述。
Front Immunol. 2018 Jul 9;9:1568. doi: 10.3389/fimmu.2018.01568. eCollection 2018.
3
Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn.卡介苗对早产儿和足月新生儿乙型肝炎疫苗免疫原性的辅助作用。
Front Immunol. 2018 Jan 24;9:29. doi: 10.3389/fimmu.2018.00029. eCollection 2018.
4
The Immune Adjuvant Effects of Flounder (Paralichthys olivaceus) Interleukin-6 on E. tarda Subunit Vaccine OmpV.牙鲆白细胞介素-6对迟缓爱德华氏菌亚单位疫苗OmpV的免疫佐剂效应
Int J Mol Sci. 2017 Jul 5;18(7):1445. doi: 10.3390/ijms18071445.
5
Bacterial ghosts as adjuvants: mechanisms and potential.作为佐剂的细菌幽灵:作用机制与潜力
Vet Res. 2017 Jun 24;48(1):37. doi: 10.1186/s13567-017-0442-5.
6
Improved lysis efficiency and immunogenicity of Salmonella ghosts mediated by co-expression of λ phage holin-endolysin and ɸX174 gene E.通过共表达 λ 噬菌体 holin-内溶素和 φX174 基因 E,提高了 Salmonella 噬菌体的裂解效率和免疫原性。
Sci Rep. 2017 Mar 23;7:45139. doi: 10.1038/srep45139.
7
Protective efficacy of a broadly cross-reactive swine influenza DNA vaccine encoding M2e, cytotoxic T lymphocyte epitope and consensus H3 hemagglutinin.编码 M2e、细胞毒性 T 淋巴细胞表位和共识 H3 血凝素的广谱交叉反应性猪流感 DNA 疫苗的保护效力。
Virol J. 2012 Jun 27;9:127. doi: 10.1186/1743-422X-9-127.
8
GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates.GM-CSF 增强了 H1N1 流感 DNA 疫苗经皮接种于非人灵长类动物后的黏膜和系统免疫原性。
PLoS One. 2010 Jun 8;5(6):e11021. doi: 10.1371/journal.pone.0011021.
9
Consequences of CXCL10 and IL-6 induction by the murine IFN-alpha1 transgene in ocular herpes simplex virus type 1 infection.小鼠IFN-α1转基因在单纯疱疹病毒1型眼部感染中诱导CXCL10和IL-6的后果。
Immunol Res. 2004;30(2):191-200. doi: 10.1385/IR:30:2:191.
10
Antiviral protection after DNA vaccination is short lived and not enhanced by CpG DNA.DNA疫苗接种后的抗病毒保护作用持续时间较短,且不会因CpG DNA而增强。
Immunology. 2000 Feb;99(2):163-9. doi: 10.1046/j.1365-2567.2000.00950.x.

本文引用的文献

1
Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus.用颗粒介导的甲型流感病毒DNA疫苗免疫猪可使其免受同源病毒攻击。
J Virol. 1998 Feb;72(2):1491-6. doi: 10.1128/JVI.72.2.1491-1496.1998.
2
Manipulation of immune responses via particle-mediated polynucleotide vaccines.通过颗粒介导的多核苷酸疫苗对免疫反应进行调控。
Behring Inst Mitt. 1997 Feb(98):73-8.
3
Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice.
Vaccine. 1997 Jul;15(10):1149-56. doi: 10.1016/s0264-410x(96)00309-x.
4
Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine.流感血凝素DNA疫苗诱导的体液免疫反应的特征
Vaccine. 1997 Jan;15(1):71-8. doi: 10.1016/s0264-410x(96)00101-6.
5
Antibody responses and protection in mice immunized orally against influenza virus.口服免疫小鼠对抗流感病毒的抗体反应及保护作用。
Vaccine. 1996 Dec;14(17-18):1651-6. doi: 10.1016/s0264-410x(96)00128-4.
6
Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2.通过共表达乙型肝炎表面抗原和白细胞介素-2的质粒改进乙型肝炎病毒DNA疫苗。
J Virol. 1997 Jan;71(1):169-78. doi: 10.1128/JVI.71.1.169-178.1997.
7
DNA vaccines for emerging infectious diseases: what if?用于新发传染病的DNA疫苗:倘若……会怎样?
Emerg Infect Dis. 1996 Jul-Sep;2(3):168-75. doi: 10.3201/eid0203.960302.
8
Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus.用表达新城疫病毒F蛋白的线性质粒DNA疫苗接种保护鸡免受新城疫侵害。
Vaccine. 1996 Jun;14(8):747-52. doi: 10.1016/0264-410x(95)00254-x.
9
Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12.通过接种耶尔森氏菌HSP60免疫刺激复合物或耶尔森氏菌HSP60加白细胞介素-12获得针对小肠结肠炎耶尔森氏菌的免疫力。
Infect Immun. 1996 Aug;64(8):2955-61. doi: 10.1128/iai.64.8.2955-2961.1996.
10
Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases.细胞因子作为疫苗佐剂用于预防传染病的现状。
Clin Infect Dis. 1995 Dec;21(6):1439-49. doi: 10.1093/clinids/21.6.1439.